<?xml version="1.0" encoding="UTF-8"?>
<p>In this study, formalin-inactivated EV71 vaccine (FI-EV71) derived from a patient who showed clinical signs of HFMD and belonged to the C4 subgenogroup was developed, and the efficacy of FI-EV71 with various adjuvants was evaluated in mice. Our results provide a foundation for the development of inactivated EV71 whole-virus vaccines.</p>
